| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.089 | 0.06 |